SFG
PTCT icon

Steward Financial Group’s PTC Therapeutics PTCT Stock Holding History

Steward Financial Group’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$0 Buy
+15
New +$558 ﹤0.01% 1512
2023
Q2 		– Sell
-16
Closed – – 874
2023
Q1 		$0 Buy
16
+13
+433% +$594 ﹤0.01% 874
2022
Q4 		$0 Buy
+3
New +$125 ﹤0.01% 758

Other funds holding PTCT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Steward Financial Group's PTCT Position: Q3 2023 in Review

Steward Financial Group opened a new position in PTC Therapeutics (PTCT) in Q3 2023: 15 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1512 among its holdings. This is a return to the name: Steward Financial Group previously reported a position in PTCT as recently as Q1 2023.

Steward Financial Group first reported a position in PTCT in Q4 2022 and has held it in 3 quarters since. 179 funds tracked by Wall St. Rank hold PTCT as of Q3 2023.

  • Steward Financial Group held 15 shares of PTC Therapeutics worth $0 as of Q3 2023.
  • PTC Therapeutics was a new Steward Financial Group position in Q3 2023.
  • PTC Therapeutics made up ﹤0.01% of Steward Financial Group's portfolio in Q3 2023, its #1512 holding.
  • Steward Financial Group first reported a position in PTC Therapeutics in Q4 2022 and has held it in 3 quarters since.
  • 179 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.